Publication | Open Access
Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices
96
Citations
14
References
2012
Year
Lymphoid NeoplasiaNational Lymphocare StudyEpidemiologyMedicinePathologyCancer RegistrationOncologyCancer ResearchCommunity Practices
| Year | Citations | |
|---|---|---|
1993 | 3.5K | |
2004 | 1.5K | |
2009 | 736 | |
2009 | 291 | |
2005 | 261 | |
2005 | 239 | |
The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcome | 2006 | 217 |
2008 | 216 | |
2006 | 200 | |
2000 | 184 |
Page 1
Page 1